Tag: Natco Pharma
Natco Pharma launches FDC Trifluridine & Tipiracil first time in India
Natco Pharma Limited has launched a novel fixed-dose combination (FDC) of trifluridine and tipiracil for the first-time in India under the brand...
These Indian Pharma Cos seek nod from DCGI for marketing Anti...
Hyderabad-based Natco Pharma Limited and Hetero have sought marketing authorisation for their anti-Covid drug molnupiravir from the drug regulator, people in the know told ET.
The Subject...
Natco Pharma launches higher strength Anti Cancer generic drug
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in...
Natco gets USFDA nod for Carfilzomib Injection
Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical has received approval for its Abbreviated New Drug Application (ANDA) for Carfilzomib Vials...
NATCO Pharma gets USFDA nod for Everolimus tablets
Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) has announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for...
Natco Pharma gets USFDA nod for Lenalidomide capsules
Natco Pharma Limited has received the final approval of its Abbreviated New Drug Application (ANDA) for lenalidomide capsules, 5mg, 10mg, 15mg, and...
NATCO applies to CDSCO for EUA of Molnupiravir capsules
Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of Phase-III clinical trial of Molnupiravir...
NATCO gets tentative USFDA nod for Ibrutinib tablets
NATCO Pharma is pleased to announce that its marketing and distribution partner Alvogen Pine Brook LLC, has received tentative approval for our...
NATCO gets USFDA nod for Breast Cancer treatment drug
Natco Pharma’s marketing partner, Breckenridge Pharmaceutical, has received final approval for its Abbreviated New Drug Application (ANDA) for Everolimus Tablets (generic for...
NATCO launches Epilepsy Tablets in India
Natco Pharma announced the launch of Brivaracetam tablets under brand BRECITA in India.
Brivaracetam is indicated for the treatment...
USFDA approves Pomalidomide capsules for Natco
Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical, has received final approval for its Abbreviated New Drug Application (ANDA) for Pomalidomide...
Natco Pharma to launch 8-10 new drugs in India yearly
Hyderabad: Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday. "Our strategy remains...
Natco Pharma gets EIR from USFDA
Natco Pharma Limited has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for Kothur's formulation facility.
Natco Pharma completes USFDA inspection
The formulation facility of Natco Pharma in Kothur village, near Hyderabad, has received a single observation at the end of a pre-approval...
Latest posts
No need to panic over new Covid-19 variant: ICMR
New Delhi: Amid mounting concern over cases of the new variant of concern Omicron detected in some countries, the Indian Council of Medical Research...
Authors
